Luciana M. Fiuza

Luciana M. Fiuza

Auto-generated profile, based on publicly available information

Luciana M. Fiuza

Laboratório de Investigação em Genética e Hematologia Translacional, Instituto Gonçalo Moniz, FIOCRUZ-BA, Salvador 40296-710, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
RSRayra P. Santiago
Rayra P. Santiago
CFCamylla V. B. Figueiredo
Camylla V. B. Figueiredo
LFLuciana M. Fiuza
Luciana M. Fiuza
SYSetondji Cocou Modeste Alexandre Yahouédéhou
Setondji Cocou Modeste Alexandre Yahouédéhou
RORodrigo M. Oliveira
Rodrigo M. Oliveira
MGMarilda Souza Gonçalves
Marilda Souza Gonçalves
Individuals with sickle cell disease (SCD) present both chronic and acute inflammatory events. The TGF-β pathway is known to play a role in immune response, angiogenesis, inflammation, hematopoiesis, vascular inflammation, and cell proliferation. Polymorphisms in the transforming growth factor-beta receptor 3 (TGFBR3) gene have been linked to several inflammatory diseases. This study investigated associations between two TGFBR3 haplotypes and classical laboratory parameters, as well as clinical manifestations, in SCD. We found that individuals with the GG haplotype presented higher levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides, non-HDL cholesterol, total proteins, and globulin than individuals with non-GG haplotypes. In addition, the GG haplotype was associated with a previous history of pneumonia. Individuals with the CGG haplotype presented increased plateletcrit, TC, LDL-C levels, and non-HDL cholesterol. The CCG haplotype was also associated with a previous history of pneumonia. Our findings suggest that individuals with the GG and CGG haplotypes of TGFBR3 present important alterations in lipid profile.